Article
Long-term treatment and diagnosis of tetrahydrobiopterin-responsive hyperphenylalaninemia with a mutant phenylalanine hydroxylase gene.
Pediatric research - 1 Mar 2004
Shintaku Haruo, Kure Shigeo, Ohura Toshihiro, Okano Yoshiyuki, Ohwada Misao, Sugiyama Naruji, Sakura Nobuo, Yoshida Ichiro, Yoshino Makoto, Matsubara Yoichi, Suzuki Ken, Aoki Kikumaro, Kitagawa Teruo
Abstract excerpt
A novel therapeutic strategy for phenylketonuria (PKU) has been initiated in Japan. A total of 12 patients who met the criteria for tetrahydrobiopterin (BH(4))-responsive hyperphenylalaninemia (HPA) with a mutant phenylalanine hydroxylase (PAH) (EC 1.14.16.1) gene were recruited at 12 medical centers in Japan between June 1995 and July 2001. Therapeutic efficacy of BH(4) was evaluated in single-dose, four-dose,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
